LinkMed logo
sp
sp divider
The LinkMed portfolio consists of a number of life science companies, several of which are nearing the commercialization phase, while others are already selling their products or services. Between them, these companies account for more than 50 different projects in a wide range of therapeutic areas – from HIV and cancer to eye disease and allergies.
COMPANIES IN SEVERAL SECTORS
LinkMed has created a portfolio of twelve companies, four in drug development and biotechnology and eight in diagnostics and medical technology
MANY COMPANIES, LOWER RISKS
By investing in several companies, we spread risks and reduce our exposure to the development in individual projects. Our goal is to continually develop and manage between 15 and 20 portfolio companies. Therefore, we plan to invest in several new companies in the coming years.
OlerupIntl

Olerup International AB

Operations: Olerup International is a global sales and distribution company with two wholly owned subsidiaries, Olerup GmbH and Olerup Inc. Initially, Olerup International will handle sales and distribution of Olerup SSP’s HLA typing as well as AbSorber’s transplantation test XM-ONE®.

Olerup GmbH, domiciled in Vienna, Austria, will cover the European and Asian markets. Olerup Inc., domiciled in West Chester, PA, will cover the North American market.

Sektor: Diagnostics and medical technology distributor

CEO: Anders Karlsson

Chairman: Ingemar Lagerlöf

Venture manager: Ingemar Lagerlöf

Ownership stake: 25%

Address: Olerup International AB
Box 7710
SE-10395 Stockholm
Sweden

www.olerup.com

Back